ID | 30703 |
JaLCDOI | |
FullText URL | |
Author |
Ohnoshi, Taisuke
Oka, Akira
Hayashi, Kyoichi
Ueoka, Hiroshi
Sato, Masaharu
Nishihara, Ryuji
Yasuoka, Masatoshi
Sando, Yasuhiro
Tanaka, Toshio
Kimura, Ikuro
|
Abstract | Eighteen patients with advanced non-Hodgkin's lymphoma other than the diffuse histiocytic type were treated with a combination of adriamycin, vincristine, ifosfamide and prednisolone (AVIP). The objective response rate was 83% (15/18); 61% (11/18) achieved complete remission. The median duration of complete remission was 11 months ranging from 2 to 39+ months. Eleven of the 18 patients are still alive during the median follow-up time of 13 months. The median survival was 14+ months for complete responders, and 9.5 months for partial and nonresponders. A myelosuppressive toxicity was well tolerated. AVIP offers some hope as treatment of advanced non-Hodgkin's lymphoma. |
Keywords | non-Hodgkin's lymphoma
combination chemotherapy
|
Amo Type | Article
|
Publication Title |
Acta Medica Okayama
|
Published Date | 1982-02
|
Volume | volume36
|
Issue | issue1
|
Publisher | Okayama University Medical School
|
Start Page | 67
|
End Page | 72
|
ISSN | 0386-300X
|
NCID | AA00508441
|
Content Type |
Journal Article
|
language |
English
|
File Version | publisher
|
Refereed |
True
|
PubMed ID | |
Web of Science KeyUT |